Latest Articles

Publication Date
Advanced Age as a Predictor of Unsuccessful Bilateral Sentinel Lymph Node Detection Using Radiocolloid Mapping in Patients With Endometrial Cancer: A Prospective Observational Study - Cureus

Advanced Age as a Predictor of Unsuccessful Bilateral Sentinel Lymph Node Detection Using Radiocolloid Mapping in Patients With Endometrial Cancer: A Prospective Observational Study Cureus

Published: May 24, 2025, 12:37 a.m.
Told It’s ‘All in Your Head’? Medical Gaslighting Can Wreck Patients’ Health For Years - Study Finds

Told It’s ‘All in Your Head’? Medical Gaslighting Can Wreck Patients’ Health For Years Study Finds

Published: May 21, 2025, 9:50 p.m.
Told It’s ‘All in Your Head’? Medical Gaslighting Can Wreck Patients’ Health For Years - NewsBreak: Local News & Alerts

Told It’s ‘All in Your Head’? Medical Gaslighting Can Wreck Patients’ Health For Years NewsBreak: Local News & Alerts

Published: May 21, 2025, 5:54 p.m.
When Doctors Don’t Believe Their Patients - UConn Today

When Doctors Don’t Believe Their Patients UConn Today

Published: May 21, 2025, 11:05 a.m.
When Doctors Don't Believe Their Patients - Mirage News

When Doctors Don't Believe Their Patients Mirage News

Published: May 21, 2025, 11:04 a.m.
Endometriosis patient: ‘Don't stop asking questions until you have an answer' - NBC Boston

Endometriosis patient: ‘Don't stop asking questions until you have an answer' NBC Boston

Published: May 20, 2025, 12:07 a.m.
Patient tells board of ‘dismissed symptoms’ during hospital stay in Hertfordshire - Harrow Online

Patient tells board of ‘dismissed symptoms’ during hospital stay in Hertfordshire Harrow Online

Published: May 19, 2025, 10:22 a.m.
Serous Borderline Ovarian Tumor and Extensive Abdominopelvic Endometriosis Mimicking Advanced Epithelial Ovarian Cancer in a Postmenopausal Patient - Frontiers

Serous Borderline Ovarian Tumor and Extensive Abdominopelvic Endometriosis Mimicking Advanced Epithelial Ovarian Cancer in a Postmenopausal Patient Frontiers

Published: May 16, 2025, 7:47 p.m.
Breakthrough: Acrivon's Cancer Drug Shows 35% Response Rate in Resistant Endometrial Cancer Patients - Stock Titan

Breakthrough: Acrivon's Cancer Drug Shows 35% Response Rate in Resistant Endometrial Cancer Patients Stock Titan

Published: May 14, 2025, 8:10 p.m.
VIDEO: Puxitatug samrotecan shows promise for patients with recurrent endometrial cancer - Healio

VIDEO: Puxitatug samrotecan shows promise for patients with recurrent endometrial cancer Healio

Published: May 14, 2025, 8:04 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!